Personal review: Helicobacter pylori, NSAIDs and cognitive dissonance

Alimentary Pharmacology and Therapeutics

Volumn 13, Issue 6, 1999, Pages 695-702

  Hawkey, C J ^a  

^a NOTTINGHAM UNIVERSITY HOSPITALS NHS TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

NONSTEROID ANTIINFLAMMATORY AGENT; OMEPRAZOLE; PROSTAGLANDIN; RANITIDINE;

COGNITION; GASTROINTESTINAL ENDOSCOPY; GRAM NEGATIVE INFECTION; HELICOBACTER PYLORI; HUMAN; PEPTIC ULCER; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS; REVIEW; RISK FACTOR; STOMACH MUCOSA;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; COGNITIVE DISSONANCE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; PEPTIC ULCER;

EID: 0033042199     PISSN: 02692813     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2036.1999.00550.x     Document Type: Review

References (62)

1. 1 Festinger L, Riecken HW Jr, Schachter S. When Prophecy Fails. Minneapolis: University of Minnesota Press, 1956.
2. 2 Festinger LA. Theory of Cognitive Dissonance. New York: Row, Peterson, 1957.
3. 3 Chapman S, Wai Leng Wong. Smith W. Self-exempting beliefs about smoking and health: Differences between smokers and ex-smokers. Am J Public Health1993; 83: 215-9.
4. 4 Marshalll BJ, Warren JR. Unidentified curved bacilli in the stomachs of patients with gastitis and peptic ulceration. Lancet 1984; 1: 1311-4.
5. 5 Hawkey CJ. Non-steroidal anti-inflammatory drugs and ulcers: Facts and figures multiply, but do they add up? Br Med J 1990; 300: 278-84.
6. 6 Peek RM Jr, Blaser MJ. Pathophysiology of Helicobacter pylori-induced gastritis and peptic ulcer disease. Am J Med 1997; 102: 200-7.
7. 7 Atherton JCH. pylori virulence factors. Br Med Bull 1998; 54: 105-20.
8. 8 Wallace JL, Bell CJ. Gastroduodenal mucosal defense. Curr Opin Gastroenterol 1996; 12: 503-11.
9. 9 NIH, Consensus Conference. Helicobacter pylori in peptic ulcer disease. J Am Med Assoc 1994; 272: 65-9.
10. 10 Chan FKL, Sung JY, Chung SCS, et al. Does eradication of H. pylori prevent NSAID-induced ulcers? A prospective randomised study. Gastroenterology 1997; 112: A85(Abstract).
11. 11 European Helicobacter pylori Study Group. Current European concepts in the management of Helicobacter pylori infection. The Maastricht Consensus Report Gut 1996; 41: 8-13.
12. 12 Cullen DJE, Hawkey GM, Greenwood DC, et al. Peptic ulcer bleeding in the elderly: relative roles of Helicobacter pylori and non-steroidal anti-inflammatory drugs. Gut 1997; 41: 459-62.
13. 13 Aalykke C, Lauritsen JM, Hallas J, Reinholdt S, Krogfelt K, Lauritsen K. Helicobactor pylori-a risk factor in NSAID-related bleeding peptic ulcer: a prospective case control study. Gastroenterology 1997; 122: A51 (Abstract).
14. 14 Reinbach DH, Cruickshank G, McColl KEL. Acute perforated duodenal ulcer is not associated with Helicobactor pylori infection. Gut 1993; 34: 1344-7.
15. 15 Debongnie J-C, Wibin E, Timmermans M, Mairess J, Dekonick X. Are perforated gastroduodenal ulcers related to Helicobactor pylori infection? Acta Gastro-Enterologicia Belgica 1995; 58: 208-12.
16. 16 Hawkey CJ. Are NSAIDs and Helicobacter pylori separate risk factors? In: Hunt RH, Tytgat GNJ, eds. Helicobacter pylori. Basic Mechanisms to Clinical Cure. MA, USA: Kluwer Academic Publishers, 1996: 312-23.
17. 17 Lanza RL, Evans DG, Graham DY. Effect of Helicobacter pylori infection on the severity of gastroduodenal mucosal injury after acute administration of naproxen or aspirin to normal volunteers. Am J Gastroenterol 1991; 86: 735-7.
18. 18 Laine L, Cominelli Sloane R, Casini-Raggi V, Marin-Sorensen. Interaction of NSAIDs and Helicobacter pylori on gastrointestinal injury and prostaglandins production: a controlled double-blind trial. Aliment Pharmacol Ther 1995; 9: 127-35.
19. 19 Thillainayagam AV, Tabaqchali S, Warrington SJ, Farthing MJG. Interrelationships between Helicobacter infection, non-steroidal anti-inflammatory drugs and gastroduodenal disease: a prospective study in healthy volunteers. Dig Dis Sci 1994; 39: 1085-9.
20. 20 Goggin PM, Collins DA, Juzrawj RP, et al. Helicobacter pylori infection and its effect on symptoms and non-steroidal anti-inflammatory drug induced gastrointestinal damage in patients with rheumatoid arthritis. Gut 1993; 34: 1677-80.
21. 21 Giral A, Ozdogan CA, Celikel NB, Ulusoy N, Tozun Kalyci C. Does eradication of H. pylori reduce low dose aspirin induced gastroduodenal injury? Gastroenterology 1997; 112: A127(Abstract).
22. 22 Graham DY, Lidsky MD, Cox AM., et al. Long term non-steroidal anti-inflammatory drug use and Helicobacter pylori infection. Gastroenterology 1991; 100: 1652-7.
23. 23 Martin DF, Montgomery E, Dobek AS, Patrissi GA, Puera DA, Campylobacter pylori, NSAIDs and smoking - risk factors for peptic ulcer disease. Am J Gastroenterol 1989; 84: 1268-72.
24. 24 Shallcross TM, Heatley RV. Effect of non-steroidal anti-inflammatory drugs on dyspeptic symptoms. Br Med J 1990; 300: 368-9.
25. 25 Hudson N, Balsitis M, Filipowicz B, Hawkey CJ. Effect of Helicobacter pylori colonisation on gastric mucosal eicosanoid synthesis in patients taking non-steriodal anti-inflammatory drugs. Gut 1993; 34: 748-51.
26. 26 Janssen M, Dijkmans BAC, Lamers CBHW, Zwinderman AH, Vandenbroucke JP. A gastroscopic study of the predictive value of risk factors for non-steroidal anti-inflammatory drug-associated ulcer disease in rheumatoid arthritis patients. Br J Rheumatol 1994; 33: 449-54.
27. 27 Taha AS, Dahil S, Sturrock RD, Lee FD, Russell RI. Predicting NSAID related ulcers-assessment of clinical and pathological risk, factors and importance of differences in NSAID. Gut 1994; 35: 891-5.
28. 28 Caselli M, Pazzi P, LaCorte Raleott A, Trevisani L, Stabellini G. Campylobacter-like organisms, non-steroidal anti-inflammatory drugs and gastric lesions in patients with rheumatoid arthritis. Digestion 1989; 44: 101-4.
29. 29 Taha AS, Nakshabendi I, Lee FD, Sturrock RD, Russell RI. Chemical gastritis and Helicobacter pylori related gastritis in patients receiving NSAIDs: comparison and correlation with peptic ulceration. J Clin Pathol 1992; 45: 135-9.
30. 30 Safe AF, Warren B, Corfield A, et al. Helicobactor pylori infection in elderly people - correlation between histology and serology. Age Ageing 1993; 22: 215-20.
31. 31 Kim JG, Graham DY. & the Misoprostol Study Group. Helicobacter pylori infection and development of gastric or duodenal ulcer in arthritic patients receiving chronic NSAID therapy. Am J Gastroenterol 1994; 89: 203-7.
32. 32 Upadhyay R, Howatson A, McKinlay A, Danesh BJZ, Sturrock RD, Russell RI. Campylobacter pylori-associated gastritis in patients with rheumatoid arthritis taking non steriodal anti-inflammatory drugs. Br J Rheumatol 1988; 27: 113-6.
33. 33 Doube A, Morris A. Non-steroidal anti-inflammatory drug-induced dyspepsia - is Campylobacter pyloridis implicated? Br J Rheumatol 1988; 27: 110-2.
34. 34 Jones STM, Clague RB, Eldridge J, Jones DM. Serological evidence of infection with Helicobacter pylori may produce gastrointestinal intolerance to non-steroidal anti-inflammatory drug (NSAID) treatment in rheumatoid arthritis. Br J Rheumatol 1991; 30: 16-20.
35. 35 Yeomans ND), Tulassay Z, Juhasz L, et al. A comparison of omeprazole and ranitidine for treating and preventing ulcers associated with non-steroidal anti-inflammatory drugs. New Engl J Med 1998; 338: 719-26.
36. 36 Hawkey CJ, Jeffrey AK, Szczepnski L, et al. for the OMNIUM Study Group. A comparison of omeprazole and misoprostol for treating and preventing ulcers associated with non-steroidal anti-inflammatory drugs. New Engl J Med 1998; 338: 727-34.
37. 37 Chan FKL, Sung JJY, Chung SCS, et al. Randomised eradication of H. pylori before non-steroidal anti-inflammatory drug therapy to prevent peptic ulcers. Lancet 1997; 350: 975-9.
38. 38 Konturek SJ, Bilski J, Kwiecien N, Obtulowicz W, Kopp B, Olesky J. De-Nol stimulates gastric and duodenal alkaline secretion through prostaglandin dependant mechanism. Gut 1987; 28: 1557-63.
39. 39 Mertz-Nielsen A, Steenberg P, Neumark T, Bukhave K, Rask-Madsen J. Colloidal bismuth subcitrate caused sustained release of gastric mucosal Prostaglandin E2. Aliment Pharmacol Ther 1991; 5: 127-33.
40. 40 Gavey CJ, Szeto ML, Nwokolo CU, Sercombe J, Pounder RE. Bismuth accumulates in the body during treatment with tri-potassium dicitrato bismuthate. Aliment Pharmacol Ther 1989; 3: 21-8.
41. 41 Hawkey CJ, Tullasay Z, Szczepanski L, et al. A randomised controlled trial of Helicobacter pylori eradication in patients taking non-steroidal anti-inflammatory drugs: the HELP NSAIDs study. Lancet 1998; in press:.
42. 42 Chan FKL, Sung JY, Suen R, et al. Eradication of H. pylori versus maintenance acid suppression to prevent recurrent ulcer haemorrhage in high risk NSAID users. A prospective randomised study. Gastroenterology 1998; 114: A87(Abstract).
43. 43 Labenz J, Tillenburg B, Peitz U, et al. Helicobacter pylori augments the pH-increasing effect of omeprazole in patients with duodenal ulcer. Gastroenterology 1996; 110: 725-32.
44. 44 Labenz J, Tillenburg B, Peitz U, et al. Effect of curing Helicobacter pylori infection on intragastric acidity during treatment with ranitidine in patients with duodenal ulcer. Gut 1997; 41: 33-6.
45. 45 Daneshmend TK, Pritchard PH, Bhaskar NK, Millns P, Hawkey CJ. Use of microbleeding and an ultrathin endoscope to assess gastric mucosal protection by famotidine. Gastroenterology 1989; 97: 944-9.
46. 46 Daneshmend TK, Stein AG, Bhaskar NK, Hawkey CJ. Abolition by omeprazole of aspirin induced gastric mucosal injury in man. Gut 1990; 31: 514-7.
47. 47 Walt RP, De Gomes MFA, Wood EC, et. al. Effect of daily oral omeprazole on 24 hour intragastric acidity. Br Med J 1983; 287: 12-4.
48. 48 Szabo S, Sandor Z. Basic fibroblast growth factor and PDGF in GI diseases. Baillieres Clin Gastroenterol 1996; 10: 97-112.
49. 49 Samloff IM. Pepsinogens, pepsins and pepsin inhibitors. Gastroenterology 1971; 60: 586-604.
50. 50 Whittle BJR. Temporal relationship between cyclooxygenase inhibition, as measured by prostacyclin biosynthesis, and the gastrointestinal damage induced by indomethacin in the rat. Gastroenterology 1981; 80: 94-8.
51. 51 Watanabe T, Tada M, Nagai H, Sasaki S, Nakao M. Helicobacter pylori infection induces gastric cancer in mongolian gerbils. Gastroenterology 1998; 115: 642-8.
52. 52 Thun MJ. NSAID use and decreased risk of gastrointestinal cancers. Gastroenterol Clinics North Am 1996; 25: 333-48.
53. 53 Jensen DM, Cheng S, Kovacs TOG, et al. A controlled study of ranitidine for the prevention of recurrent haemorrhage from duodenal ulcer. New Engl J Med 1994; 330: 382-6.
54. 54 Penston JG, Wormsley KG. Nine years of maintenance treatment with ranitidine for patients with duodenal ulcer disease. Aliment Pharmacol Ther 1992; 6: 629-45.
55. 55 Graham DY, Hepps KS, Ramirez FC, Lew GM, Saeed ZA. Treatment of Helicobacter pylori reduces the rate of rebleeding in peptic ulcer disease. Scand J Gastroenterol 1993; 23: 939-42.
56. 56 Labenz J. Borsch G. Role of Helicobacter pylori eradication in the prevention of peptic ulcer bleeding relapse. Digestion 1994; 55: 19-23.
57. 57 McColl KEL. The role of Helicobacter pylori eradication in the management of acute bleeding peptic ulcer. Eur J Gastroenterol Hepatol 1995; 7: 753-5.
58. 58 Silverstein FE, Graham DY, Senior JR. et al. Misoprostol reduces serious gastrointestinal complications in patients with rheumatoid arthritis receiving non-steriodal anti-inflammatory drugs. Ann Intern Med 1995; 123: 241-9.
59. 59 Blaser MJ. Ecology of Helicobacter pylori in the human stomach. J Clin Invest 1997; 100: S67-S70.
60. 60 Lanza F, Simon T, Quan H, et al. Selective Inhibition Cyclooxygenase-2 (COX-2) with MK-0966(250 mg qd) is associated with less gastroduodenal damage than aspirin (ASA) 650 mg qid or ibuprofen (IBU) 800 mg tid. Gastroenterology; 112: A194(Abstract).
61. 61 Lanza F, Rack MF, Callison DA, et al. A pilot study of the effects of SC-58635, a novel COX-2 selective inhibitor. Gastroenterology 1997; 112: A194(Abstract).
62. 62 Stack WA, Hawkey GM, Atherton JC, et al. NSAIDs and CagA positive H. pylori but not CagA negative H. pylori as independent risk factors for bleeding peptic ulcers. Gastroenterology 1998; 114: A294(Abstract).